7
|
Jia L, Lin H, Oppenheim J, Howard OMZ, Li J, Fan H, Zhao Z, Farrar W, Zhang Y, Colburn N, Young MR, Li W, Newman D, O'Keefe BR, Beutler J, Liu J, Hao X, Yang X, Ji T, White JD. US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer. J Natl Cancer Inst Monogr 2018; 2017:4617822. [PMID: 29140488 DOI: 10.1093/jncimonographs/lgx007] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2017] [Accepted: 08/08/2017] [Indexed: 12/13/2022] Open
Abstract
Since 2007, the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM), together with the Cancer Institute of the China Academy of Chinese Medical Sciences (CICACMS), institutes at China Academy of Sciences and Chinese Academy of Medical Sciences, have engaged in collaborations on Chinese medicine (CM) and cancer research. Through these collaborations, CM drugs and compounds have been studied at NCI labs. This paper summarizes the discoveries and progress on these research projects, exploring the aspects of cancer prevention, botanical drug mechanisms of action and component analysis/quality control (QC), and anticancer activity screening. These and other related projects have been presented in various jointly convened workshops and have provided the backdrop for establishing a new organization, the International Consortium for CM and Cancer, to promote international collaborations in this field.
Collapse
Affiliation(s)
- Libin Jia
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Hongsheng Lin
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Joost Oppenheim
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - O M Zack Howard
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Jie Li
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Huiting Fan
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Zhizheng Zhao
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - William Farrar
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Ying Zhang
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Nancy Colburn
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Matthew R Young
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Weidong Li
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - David Newman
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Barry R O'Keefe
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - John Beutler
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Jikai Liu
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Xiaojiang Hao
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Xiaosheng Yang
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Tengfei Ji
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| | - Jeffrey D White
- Office of Cancer Complementary and Alternative Medicine, Division of Cancer Treatment and Diagnosis, and Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, MD; Cancer Institute, China Academy of Chinese Medical Sciences, Beijing, China; Laboratory of Molecular Immunoregulation, Laboratory of Cancer Prevention, Molecular Targets Laboratory, Center for Cancer Research, National Cancer Institute, Frederick, MD; Natural Products Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Frederick, MD; Kunming Institute of Botany, China Academy of Sciences, Kunming, China; Key Laboratory of Chemistry for Natural Products in Guizhou Province, China Academy of Sciences, Gui Yang, China; Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing, China
| |
Collapse
|